In these medical centers 2,000 relevant medical procedures are performed annually and MCS believes that its penetration level will reach 20% in the first year.
MCS Medical Compression Systems (DBN) Ltd. (TASE:MDCL) has notified the Tel Aviv Stock Exchange that during March four more medical centers in the US adopted the non-invasive device that it has developed for the prevention of blood clots during orthopedic surgery for deep vein thrombosis. The medical centers are in Missouri, Oregon, Ohio and Minnesota.
In these medical centers 2,000 relevant medical procedures are performed annually and MCS believes that its penetration level will reach 20% in the first year. The company already has approval from the US Food and Drug Administration (FDA) for the marketing of its product and a CE mark for marketing in Europe.
The company's share closed unchanged at NIS 1.08.
Published by Globes [online], Israel business news - www.globes-online.com - on April 6, 2010
© Copyright of Globes Publisher Itonut (1983) Ltd. 2010